Expression of a Soluble Transforming Growth Factor-β (TGFβ) receptor reduces tumorigenicity by regulating natural killer (NK) cell activity against 9L gliosarcoma in vivo
Year: 2003
Type: article
Source: Journal of Neuro-Oncology
DOI: 10.1007/bf02700021
Institutions: UPMC Hillman Cancer Center, University of Pittsburgh
Language: English
Subfield: Genetics (clinical)
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2042360792
